Correlation Between Cigna Corp and Boston Scientific

Can any of the company-specific risk be diversified away by investing in both Cigna Corp and Boston Scientific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and Boston Scientific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cigna Corp and Boston Scientific Corp, you can compare the effects of market volatilities on Cigna Corp and Boston Scientific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of Boston Scientific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and Boston Scientific.

Diversification Opportunities for Cigna Corp and Boston Scientific

-0.5

Correlation Coefficient

Cigna Corp  Boston Scientific

Very good diversification

The 3 months correlation between Cigna and Boston is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and Boston Scientific Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Scientific Corp and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with Boston Scientific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Scientific Corp has no effect on the direction of Cigna Corp i.e., Cigna Corp and Boston Scientific go up and down completely randomly.

Pair Corralation between Cigna Corp and Boston Scientific

Allowing for the 90-day total investment horizon Cigna Corp is expected to under-perform the Boston Scientific. In addition to that, Cigna Corp is 1.73 times more volatile than Boston Scientific Corp. It trades about -0.06 of its total potential returns per unit of risk. Boston Scientific Corp is currently generating about 0.18 per unit of volatility. If you would invest  8,114  in Boston Scientific Corp on September 2, 2024 and sell it today you would earn a total of  952.00  from holding Boston Scientific Corp or generate 11.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cigna Corp  vs.  Boston Scientific Corp

Cigna Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's forward indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Boston Scientific Corp

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Cigna Corp and Boston Scientific

The main advantage of trading using opposite Cigna Corp and Boston Scientific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, Boston Scientific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will offset losses from the drop in Boston Scientific's long position.

The idea behind Cigna Corp and Boston Scientific Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.